Global COVID-19 Pandemic Updates Part Two: India Online CME Course

Access to online streaming course is available from the date of purchase until the course expires on December 7, 2024. Credit must be claimed within that time period.

Global COVID-19 Pandemic Updates Part Two: India

Recorded: December 7, 2021 at 12:00 p.m. – 1:30 p.m., ET

On Tuesday, December 7, from 12:00 p.m. – 1:30 p.m., ET, Mayo Clinic and other experts continue a discussion on the global impact of COVID-19. Infection prevalence, virus variants, preventative measures, vaccination status, and therapies used in treating patients in India will be addressed along with the prevalence of other infectious diseases.

  • Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine
  • Moderator: Prakash Kempaiah, Ph.D., associate consultant, Division of Infectious Diseases
  • Featured expert: Pulin Kumar Gupta, M.D., professor medicine in charge, HIV/ART Centre ABVIMS (formerly PFIMER), Dr. Ram Manohar Lohia Hospital, New Delhi, India

The views and perspectives shared in these resources are presented based on information available at the time of recording.

Learning Objectives

Upon completion of the Mayo Clinic COVID-19 Live Webinar Series course, learners should be able to:

  • Describe therapies locally used for treating COVID-19 patients
  • Give examples of preventive measures implemented by the government agencies or medical societies
  • Summarize vaccination status: Availability of types, second of mRNA doses access and impact on other vaccines in India
  • Describe the current status of COVID-19 pandemic in India

Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
12/07/2021
Course expires: 
12/07/2024
Cost:
$10.00
Part of: 
Mayo Clinic COVID-19 Live Webinar Series - December 7, 2021

Moderator: Claudia R. Libertin, M.D., consultant, Division of Infectious Diseases; professor of medicine

Moderator: Prakash Kempaiah, Ph.D., associate consultant, Division of Infectious Diseases

Featured expert: Pulin Kumar Gupta, M.D., professor medicine in charge, HIV/ART Centre ABVIMS (formerly PFIMER), Dr. Ram Manohar Lohia Hospital, New Delhi, India

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statements: 

AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Price

Cost:
$10.00
Please login or register to take this course.

Access to online streaming course is available from the date of purchase until the course expires on December 7, 2024. Credit must be claimed within that time period.

If you attended and claimed CME credit for the Live Webinar on December 7, 2021, you are unable to access the Online CME course. To view the recording, please click here.

Notify me for new episodes

Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.